| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/24/2010 | CN100591759C Animal protein free media for cultivation of cells |
| 02/24/2010 | CN100591678C Piperidine derivatives useful as CCR5 antagonists |
| 02/24/2010 | CN100591329C Montelukast granule formulation |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667027 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) |
| 02/23/2010 | US7667009 Isolating dermatophagoides protein via anion exchange and hydrophobic gel adsorption |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666881 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride formed by azeotropic distillation |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666847 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/23/2010 | US7666639 Plant deoxyribonucleoside kinase enzymes and their use |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666604 Modified soluble T cell receptor |
| 02/23/2010 | US7666581 Complexing antigenic proteins/peptides; membrane proteins; tumor associated antigens |
| 02/23/2010 | US7666441 Nucleic acids encoding peptides having at least one biological activity of Can f I or Can f II, protein allergens of the species Canis familiaris; suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander |
| 02/23/2010 | US7666439 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2344173C Immunogenic liposome compositions |
| 02/20/2010 | CA2639003A1 Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations |
| 02/18/2010 | WO2010019611A2 Bridged polycyclic compound based compositions for topical and oral applications |
| 02/18/2010 | WO2010019034A1 Use of carvacrol for treating inflammatory diseases |
| 02/18/2010 | WO2010018837A2 Protein cross-linking inhibitor |
| 02/18/2010 | WO2010018836A2 Polyglutamine aggregation inhibitor |
| 02/18/2010 | WO2010018614A1 Hydrophilic amino acid-containing preparation having improved taste |
| 02/18/2010 | WO2010018133A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010018132A1 Compounds |
| 02/18/2010 | WO2010018131A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010018130A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009139891A3 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof |
| 02/18/2010 | WO2009134962A3 Claudin-4 binding peptides, compositions and methods of use |
| 02/18/2010 | WO2009131702A3 Antibodies against fcrn and use thereof |
| 02/18/2010 | WO2009117616A3 Carbon nanotube compositions and methods of use thereof |
| 02/18/2010 | WO2009076602A8 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 02/18/2010 | US20100041756 method of modulating b cell functioning |
| 02/18/2010 | US20100041747 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/18/2010 | US20100041743 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 02/18/2010 | US20100041737 Gene Vector |
| 02/18/2010 | US20100041735 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 02/18/2010 | US20100041734 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 02/18/2010 | US20100041714 Bi-aryl aminotetralines |
| 02/18/2010 | US20100041709 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041693 Indolylmaleimide derivatives |
| 02/18/2010 | US20100041677 Inhibitors of bruton's tyrosine kinase |
| 02/18/2010 | US20100041602 Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules |
| 02/18/2010 | US20100041593 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 02/18/2010 | US20100040714 Asthma/Allergy Therapy that Targets T-lymphoctyes and/or Eosinophils |
| 02/18/2010 | US20100040678 Organic compounds |
| 02/18/2010 | US20100040652 Live attenuated catfish vaccine and method of making |
| 02/18/2010 | US20100040649 Inducible expression systems |
| 02/18/2010 | US20100040645 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent |
| 02/18/2010 | US20100040644 Methods for preparing immunogenic conjugates |
| 02/18/2010 | US20100040642 Novel peptide adjuvant for influenza vaccination |
| 02/18/2010 | US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon |
| 02/18/2010 | US20100040616 Treatment of autoimmune and inflammatory disease |
| 02/18/2010 | US20100040613 Polypeptide constructs for sublingual administration |
| 02/18/2010 | US20100040605 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040599 Therapeutic agent for rheumatoid arthritis |
| 02/18/2010 | US20100040589 Novel Compositions and Uses Thereof |
| 02/18/2010 | US20100040577 METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS |
| 02/18/2010 | CA2734379A1 Ragweed peptides for vaccine |
| 02/18/2010 | CA2734335A1 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 02/18/2010 | CA2733749A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | CA2733743A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/17/2010 | EP2154146A1 Use of african swine pest haemoglutinin as an adjuvant |
| 02/17/2010 | EP2154145A2 Dimerized peptide |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |
| 02/17/2010 | EP2153841A1 Vaccine comprising Amb 1 a peptides for use in the treatment of ragweed allergy |
| 02/17/2010 | EP2153736A1 Novel leukotriene receptor antagonist |
| 02/17/2010 | EP2152755A1 Prevention and treatment of complement-associated eye conditions |
| 02/17/2010 | EP2152750A1 Anti-mdl-1 antibodies |
| 02/17/2010 | EP2152748A1 Anti-notch1 nrr antibodies and methods using same |
| 02/17/2010 | EP2152746A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 02/17/2010 | EP2152740A1 Products for altering il-33 activity and methods therefor |
| 02/17/2010 | EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof |
| 02/17/2010 | EP2152688A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 02/17/2010 | EP2152676A1 "triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives" |
| 02/17/2010 | EP2152308A1 New indications for anti- il-i-beta therapy |
| 02/17/2010 | EP1549322B1 Lipid a and other carbohydrate ligand analogs |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | CN100589812C Plant worms mycelium extracat fraction and composition for oral intake |
| 02/16/2010 | US7662976 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662916 Modified HIV Env polypeptides |
| 02/16/2010 | US7662854 HIF hydroxylase inhibitors |